NL
ANIP icon

NWAM LLC’s ANI Pharmaceuticals ANIP Stock Holding History

NWAM LLC’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6,719
Closed -$217K – 259
2020
Q2 		$217K Buy
+6,719
New +$241K 0.03% 368
2019
Q4 		$435K Hold
7,059
– – 0.08% 241
2019
Q3 		$514K Sell
7,059
-400
-5% -$29.9K 0.1% 201
2019
Q2 		$613K Sell
7,459
-440
-6% -$31.3K 0.12% 167
2019
Q1 		$557K Sell
7,899
-140
-2% -$8.24K 0.12% 169
2018
Q4 		$362K Buy
8,039
+5
+0.1% +$262 0.09% 209
2018
Q3 		$454K Sell
8,034
-575
-7% -$35.2K 0.1% 203
2018
Q2 		$575K Sell
8,609
-298
-3% -$18.6K 0.14% 162
2018
Q1 		$519K Sell
8,907
-873
-9% -$55.4K 0.13% 172
2017
Q4 		$630K Sell
9,780
-2,132
-18% -$133K 0.16% 141
2017
Q3 		$625K Buy
11,912
+343
+3% +$16.4K 0.16% 139
2017
Q2 		$541K Sell
11,569
-825
-7% -$39.8K 0.09% 146
2017
Q1 		$614K Buy
12,394
+25
+0.2% +$1.4K 0.19% 123
2016
Q4 		$750K Sell
12,369
-310
-2% -$19K 0.25% 102
2016
Q3 		$841K Buy
12,679
+310
+3% +$19.4K 0.06% 92
2016
Q2 		$690K Buy
12,369
+840
+7% +$40.8K 0.27% 92
2016
Q1 		$388K Sell
11,529
-330
-3% -$11.2K 0.15% 139
2015
Q4 		$535K Buy
+11,859
New +$510K 0.22% 105

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

NWAM LLC's ANIP Position: Q3 2020 in Review

NWAM LLC sold out of ANI Pharmaceuticals (ANIP) in Q3 2020, closing a stake of 6,719 shares — an estimated $217K sold.

NWAM LLC first reported a position in ANIP in Q4 2015 and held it in 18 quarters. The position peaked at $841K in Q3 2016. 116 funds tracked by Wall St. Rank hold ANIP as of Q3 2020.

  • NWAM LLC reported no remaining ANI Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • NWAM LLC sold 6,719 ANI Pharmaceuticals shares in Q3 2020, an estimated $217K.
  • NWAM LLC first reported a position in ANI Pharmaceuticals in Q4 2015 and held it in 18 quarters.
  • NWAM LLC's ANI Pharmaceuticals position peaked at $841K in Q3 2016.
  • 116 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2020.

Based on NWAM LLC's 13F filing for Q3 2020, filed 16 Oct 2020.